Journal
TALANTA
Volume 85, Issue 1, Pages 694-700Publisher
ELSEVIER
DOI: 10.1016/j.talanta.2011.04.048
Keywords
Sodium ionophore; Bumetanide; Lidocaine; Na+ channel; HTS drug discovery
Categories
Funding
- FDA [R44 FD (001645)]
Ask authors/readers for more resources
We have developed a Na-quantum dot (QD) nanosensor for [Na+]i measurements. Using this Na-QD, we determined the dynamic physiological responses of [Na+]i in nonexcitable human HEK-293F cells and excitable primary rat cardiac myocytes by pharmacologically manipulating the membrane permeability to Na+, the Na-K-2Cl cotransporter, and the Na+/H+ antiporter. These data suggest that the mechanisms of [Na+]i homeostasis can now be elucidated with this novel Na-QD nanosensor. This could have a broad impact on Na+ channel drug discovery. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available